ag 127 has been researched along with Chronic Illness in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Britti, D; CalabrĂ², G; Caputi, AP; Cuzzocrea, S; De Sarro, A; Mazzon, E; Mazzullo, G; McDonald, MC; Siriwardena, D; Thiemermann, C | 1 |
1 other study(ies) available for ag 127 and Chronic Illness
Article | Year |
---|---|
The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation.
Topics: Acute Disease; Animals; Arthritis; Carrageenan; Chronic Disease; Collagen; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors; Inflammation; Isoenzymes; Lung; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pleurisy; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Tarsus, Animal; Tibia; Tyrphostins | 2000 |